Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial

202355 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet. Gastroenterology & hepatology

Volume 8, Issue 8, pp. 735-747

Field-Weighted Citation Impact: 15.41